Skip to main content
FQHC Talent

Cookie notice

Allow detailed analytics to improve the site?It's from us, Google and Vercel, and stays off until you accept. If you're signed in, it can link your visits across devices. Declining doesn't limit what you can use. Details & privacy.

Back to the news

HRSA's 340B rebate pilot started in January 2026 with 10 drugs

Federal

Issue

HRSA's first 340B rebate pilot started January 1, 2026 with 8 manufacturers and 10 drugs, including Eliquis, Enbrel, Jardiance and Stelara, Community Link Consulting noted. Health centers buy at wholesale and submit rebate claims within 45 days, which delays cash.

Audit your 340B capture rate and model the cash-flow delay.

Key points

  • HRSA's rebate pilot started January 1, 2026 with 8 manufacturers and 10 drugs, including Eliquis, Enbrel, Jardiance and Stelara.
  • Health centers buy at wholesale and claim rebates within 45 days, which changes cash-flow timing.
  • Many health centers capture only 20% to 30% of eligible 340B prescriptions, so audit your rate.
  • Use 340B software that works with your EHR, and model cash flow for delayed rebates.

Sources for this story

Community Link Consulting

Part of

Sources for your board packet

This story's source plus 4 related stories and their sources, ready to print for your team or board.

The newsletter is paused right now. Sign up and you will get it when it starts again.

Free. Unlocking the packet subscribes you to Intel Brief. You'll also get a short welcome series and the occasional product update. You'll be subscribed right away, with no confirmation email. Unsubscribe with one click in any issue. If you unsubscribed before, we won't re-add you. We never sell your email. You can open each source above without an email.

Cite this analysis

FQHC Talent. (2026, March 4). HRSA's 340B rebate pilot started in January 2026 with 10 drugs. Source: Community Link Consulting. Retrieved November 22, 2026, from https://www.fqhctalent.com/intel/strategy-340b-rebate-model-pivot